We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417B
AUM Growth
-$1.66B
Cap. Flow
+$1.91B
Cap. Flow %
0.46%
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139

Top Buys

Rank Stock Value
1
EWG icon
iShares MSCI Germany ETF
EWG
+$739M
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$723M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$662M
4
EWJ icon
iShares MSCI Japan ETF
EWJ
+$452M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$272M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$553M
2
PCYC
PHARMACYCLICS INC
PCYC
+$381M
3
QRVO icon
Qorvo
QRVO
+$377M
4
TEG
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
+$319M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$303M

Sector Composition

Rank Sector Weight
1 Healthcare 15.1%
2 Financials 12.85%
3 Technology 12.68%
4 Industrials 10.63%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOCO
3426
DELISTED
Mocon Inc
MOCO
$249K ﹤0.01%
15,611
+1,874
+14% +$31.7K
ARQL
3427
DELISTED
Arqule Inc
ARQL
$248K ﹤0.01%
155,181
-8,856
-5% -$17K
FEIM icon
3428
Frequency Electronics
FEIM
$656M
$247K ﹤0.01%
21,874
-2,596
-11% -$33.2K
ONCT
3429
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$247K ﹤0.01%
120
+65
+118% +$92.4K
SHBI icon
3430
Shore Bancshares
SHBI
$817M
$246K ﹤0.01%
26,103
– –
IMI
3431
DELISTED
Intermolecular, Inc.
IMI
$246K ﹤0.01%
125,033
+77,653
+164% +$144K
BYLK
3432
DELISTED
BAYLAKE CORP
BYLK
$246K ﹤0.01%
19,472
+2,365
+14% +$29.5K
FLNT
3433
Fluent
FLNT
$103M
$245K ﹤0.01%
+3,744
New +$175K
ESI
3434
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$243K ﹤0.01%
61,133
-578,473
-90% -$2.68M
ZN
3435
DELISTED
Zion Oil & Gas, Inc.
ZN
$242K ﹤0.01%
126,860
+15,278
+14% +$30K
NAME
3436
DELISTED
Rightside Group, Ltd.
NAME
$242K ﹤0.01%
35,807
-201,349
-85% -$1.69M
EPRS
3437
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$242K ﹤0.01%
+42,443
New +$290K
MNOV icon
3438
MediciNova
MNOV
$65.5M
$241K ﹤0.01%
60,997
+7,334
+14% +$29K
TENX icon
3439
Tenax Therapeutics
TENX
$419M
$241K ﹤0.01%
2
– –
AVEO
3440
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$241K ﹤0.01%
13,841
-966
-7% -$17.4K
HDSN
3441
Hudson Technologies
HDSN
$259M
$239K ﹤0.01%
68,347
+8,236
+14% +$32.8K
BPTH
3442
DELISTED
Bio-Path Holdings Inc
BPTH
$238K ﹤0.01%
52
-458
-90% -$2.5M
JNP
3443
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$238K ﹤0.01%
26,035
-299
-1% -$2.26K
ERII icon
3444
Energy Recovery
ERII
$433M
$237K ﹤0.01%
86,381
-958,025
-92% -$2.81M
CYBE
3445
DELISTED
Cyberoptics Corp
CYBE
$237K ﹤0.01%
23,479
+260
+1% +$2.72K
NSSC icon
3446
Napco Security Technologies
NSSC
$1.33B
$234K ﹤0.01%
81,590
-4,200
-5% -$11.6K
KIN
3447
DELISTED
Kindred Biosciences, Inc.
KIN
$234K ﹤0.01%
34,366
-259,237
-88% -$1.84M
PLNR
3448
DELISTED
PLANAR SYSTEMS INC
PLNR
$234K ﹤0.01%
53,766
+6,462
+14% +$32.9K
EVFM
3449
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$232K ﹤0.01%
+286
New +$184K
COSI
3450
DELISTED
COSI INC NEW COM STK (DE)
COSI
$232K ﹤0.01%
+115,420
New +$275K
136 137
138
139 140

Similar funds

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

BlackRock Fund Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
  • BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
  • BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
  • BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
  • BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
  • BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.